| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2199613C Indole-2,3-dione-3-oxime derivatives, their preparation and use |
| 02/29/2000 | CA2169179C 5-arylindole derivatives |
| 02/28/2000 | CA2249037A1 Novel compounds |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009669A1 Human mesencephalon cell lines and methods of use therefor |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009662A1 Transgenic nonhuman mammal and uses thereof to identify compounds useful for improving long-term memory |
| 02/24/2000 | WO2000009616A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009534A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 02/24/2000 | WO2000009501A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | WO2000009499A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009486A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009484A1 Pipecolic acid derivatives and their use for vision and memory disorders |
| 02/24/2000 | WO2000009146A1 Treatment of disease states |
| 02/24/2000 | WO2000009142A1 Methods for treatment of neurological disorders |
| 02/24/2000 | WO2000009139A2 Methods for promoting survival of myelin producing cells |
| 02/24/2000 | WO2000009130A2 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | WO2000009129A1 C3a receptor ligands |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009125A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009119A1 Hydroxamic acid derivatives as inhibitors of beta-amyloid production |
| 02/24/2000 | WO2000009109A2 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009108A2 Compositions and uses for vision and memory disorders |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009105A2 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | WO2000009104A2 Use of sulfonamides for treating vision and memory disorders |
| 02/24/2000 | WO2000009103A2 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | WO1999064421B1 Acetylcholine enhancers |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | DE19837638A1 New arylsulfonamides and analogs, are cannabinoid receptor agonists used e.g. for treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | DE19837627A1 New aminoacid esters of arylsulfonamides are useful for e.g. treating neurodegenerative diseases, pain, convulsions or bacterial or viral infections |
| 02/24/2000 | CA2344520A1 Pipecolic acid derivatives for vision and memory disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340745A1 Azepinyland linear compounds and their use for vision and memory disorders |
| 02/24/2000 | CA2340702A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340258A1 Methods for treatment of neurological disorders |
| 02/24/2000 | CA2340257A1 Treatment of disease states |
| 02/24/2000 | CA2340200A1 New pharmaceutical uses for nos inhibitors |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340180A1 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones |
| 02/24/2000 | CA2340168A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | CA2340092A1 Substituted isoquinoline derivatives and their use as anticonvulsivants |
| 02/24/2000 | CA2340053A1 C3a receptor ligands |
| 02/24/2000 | CA2339986A1 N-substituted azabicycloheptane derivatives, production and use thereof |
| 02/24/2000 | CA2339406A1 Novel esk potassium channel polypeptide and polynucleotide compositions |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2336152A1 Ureas and carbamates of n-heterocyclic carboxylic acids and isosteres for vision and memory disorders |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2336147A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 02/24/2000 | CA2336060A1 Small molecule carbamates or ureas for vision and memory disorders |
| 02/24/2000 | CA2335815A1 Compositions and uses for vision and memory disorders |
| 02/24/2000 | CA2335813A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | CA2335810A1 Use of sulfonamides for treating vision and memory disorders |
| 02/24/2000 | CA2277242A1 Process for pyrrolidinyl hydroxamic acid compounds |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980864A2 Sulphonamide derivatives |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980384A1 Pregnane 3,2o diol mono- and di-sulphates |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980381A1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| 02/23/2000 | EP0980373A1 Reverse-turn mimetics and methods relating thereto |
| 02/23/2000 | EP0980371A1 Tricyclic pyridone analogues as gaba-a receptor ligands |
| 02/23/2000 | EP0980370A1 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980368A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands |
| 02/23/2000 | EP0980362A1 Substituted heterocycles and their use in medicaments |
| 02/23/2000 | EP0980358A1 Pharmacological agents |
| 02/23/2000 | EP0980357A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors |
| 02/23/2000 | EP0980351A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments |
| 02/23/2000 | EP0980247A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain |
| 02/23/2000 | EP0980241A1 Gelatine encapsulated solution dosage forms of sertraline |
| 02/23/2000 | EP0861252B1 Naphthamide derivatives of 3 beta-amino azabicyclo octane or nonane as neuroleptic agents |
| 02/23/2000 | EP0775138B1 TETRAHYDROPYRIDINYLMETHYL DERIVATIVES OF PYRROLO 2,3-b]PYRIDINE |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/23/2000 | CN1245496A 3-pyridyl enantiomers and their use as analgesics |
| 02/23/2000 | CN1245495A N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 02/23/2000 | CN1245491A 5-cyclo indole compounds as 5-HT receptor ligands |
| 02/23/2000 | CN1245490A Sulfonyl urea derivatives and their use in control of interleukin-1 activity |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245429A Leukotriene antagonists for oral squamous cell carcinoma |
| 02/23/2000 | CN1245169A Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 02/23/2000 | CN1049660C Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049658C Pyrazolo [4,3-c] pyridines, a process for their preparation and their use as 5-serotonin reuptake inhibitors |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |